Metrics as of 10/15/2026, 11:59 PM (Berlin time), refresh in progress.
Medartis Holding Stock
Medartis Holding AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- Switzerland
- CEO
- Matthias Schupp
- Employees
- 1,428
- Market cap
- CHF1.1 B
- IPO
- 23/03/2018
Medartis Holding AG is a global medical technology firm that develops, manufactures, and distributes implantable solutions. These advanced medical devices are utilized worldwide for the surgical stabilization of bone fractures in both the upper and lower extremities, in addition to addressing complex…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Medartis Holding stock: price history
1D
+0.5%
1W
+6.1%
1M
+5.3%
6M
+8.6%
YTD
-0.9%
1Y
+8.7%
2Y
+52.5%
5Y
-22.7%
10Y
–
Next earnings date
Next earnings date
02/03/2027 (in 136 days)
Volatility around earnings
~57% stronger price swings than usual
Ask the agents about Medartis Holding
Medartis Holding stock metrics
P/E
72.83
P/B
3.86
EV/EBITDA
37.48
RETURN ON EQUITY
1.8%
NET MARGIN
3.2%
DEBT/EQUITY
0.74
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
32.6%
FLOAT SHARES
4,056,281
AVG. DAILY VOLUME (30D)
14,815
Comparable stocks
Frequently asked questions about Medartis Holding stock
What does Medartis Holding do?
Medartis Holding AG is a company in the Healthcare sector, Medical - Devices industry, headquartered in Switzerland.
The CEO is Matthias Schupp, the company employs around 1,428 people.
The IPO was on 23/03/2018; the stock trades on SIX under the ticker MED.SW.
When does Medartis Holding report next?
The next earnings date is 02/03/2027.
Around past earnings, price swings were roughly 57% stronger than usual.
Does Medartis Holding pay a dividend?
No, Medartis Holding currently does not pay a dividend.
Which stocks are comparable to Medartis Holding?
Comparable stocks include Sonova Holding, Kuros Biosciences, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences and Siemens Healthineers.
How can I get Medartis Holding stock analyzed?
Clicking "Analyze stock" lets five strategies assess Medartis Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.